Metraipolis › archive › dc_7e3cbc1edcd7

Use of Testosterone-Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series — Europe PMC PMID:42256464

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42256464
DOI
10.1155/crps/6191292
License (as archived)
solo-consultazione
Archived
2026-11-01T02:02:41.836Z
SHA-256 of the archived text
641ae066eb0b772293b440703e91e7ee12a12944c6dacf34aeff76fb94f9d1cd
Stable URL of this page
https://metraipolis.com/documento/dc_7e3cbc1edcd7

How to cite

Use of Testosterone-Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series — Europe PMC PMID:42256464 — Europe PMC (en), https://europepmc.org/article/MED/42256464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e3cbc1edcd7 (Metraipolis archive dc_7e3cbc1edcd7, sha256 641ae066eb0b772293b440703e91e7ee12a12944c6dacf34aeff76fb94f9d1cd)
BibTeX
@misc{dc7e3cbc1edcd7,
  title = {Use of Testosterone-Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series — Europe PMC PMID:42256464},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42256464},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e3cbc1edcd7; sha256 641ae066eb0b772293b440703e91e7ee12a12944c6dacf34aeff76fb94f9d1cd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256464. Agents can read the archived copy with the MCP tool read_document.